Stock Market Today: Stocks Soar on Apple Buyback News, Jobs Data The main indexes rallied hard to end the week thanks to Apple's $110 billion stock repurchase plan and a big April payrolls miss. Kiplinger · May 3, 2024
Stocks Climb as US Jobs Report Ramps Up Fed Rate Cut Expectations The S&P 500 Index ($SPX ) (SPY ) this morning is +0.86%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.81%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.65%. US stock indexes this morning are moderately higher, with the S&P 500 and Nasdaq... Barchart · May 3, 2024
Stocks Jump on Apple Earnings and Dovish Apr Payroll Report The S&P 500 Index ($SPX ) (SPY ) this morning is +1.00%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.59%. US stock indexes this morning are moderately higher, with the S&P 500 and Nasdaq... Barchart · May 3, 2024
Stocks Climb Before the Open After Fed Decision, Apple Earnings on Tap June S&P 500 E-Mini futures (ESM24) are up +0.58%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.77% this morning after Federal Reserve Chair Jerome Powell appeared to rule out the possibility of further interest-rate hikes, while investors looked ahead to a new round of U.S. economic data and… Barchart · May 2, 2024
3 Best Dividend ETFs to Buy for Passive Income High-yield dividend ETFs, such as SCHD, offer investors the ability to create a passive income stream for life at a relatively low cost. Barchart · Jan 3, 2024
The FTC should embrace proactive problem-solving The legal precedent would strongly discourage companies from trying to solve perceived problems with proposed transactions. Fortune · Dec 13, 2023
Competition cop Lina Khan’s antitrust overreach is hurting U.S. competitiveness–and destroying billions of dollars in value Antitrust overreach is hurting America's global competitiveness, with the FTC calculating industry concentration on a purely domestic basis. Fortune · Dec 7, 2023
November Buy Alert: 3 Biotech Stocks Making Gains Given the breakthrough developments and the rising need to treat chronic diseases, the biotech industry is well-positioned to generate returns. This might make buying biotech stocks like Organogenesis Holdings (ORGO), Innoviva (INVA), and Amgen (AMGN) a wise decision this November. Read on…. StockNews.com · Nov 6, 2023
Amgen (AMGN) Earnings Watch: Buy or Sell? Amgen (AMGN) is scheduled to report its third-quarter earnings soon, with Wall Street analysts expecting year-over-year improvements in revenue. However, its earnings are expected to miss the consensus estimate. Moreover, the company completed the acquisition of Horizon Therapeutics earlier this month. Considering these factors, is the stock a buy or… StockNews.com · Oct 30, 2023
Amgen cuts Horizon Therapeutics jobs at Deerfield office after acquisition 350 people will be laid off, many of them at Horizon’s U.S. base in Deerfield. Chicago Sun-Times · Oct 25, 2023
How to Enhance Your Own Strategies with POWR Ratings Wall Street is never lacking in strategy or trading ideas. In investing, if you can combine two or more strategies that align around a particular investing idea, you can enhance your likelihood of success. This idea combines our POWR Ratings with a strategy that is currently making the rounds on… StockNews.com · Oct 12, 2023
All in: Drugmakers say yes, they'll negotiate with Medicare on price, so reluctantly Despite at least nine lawsuits against the government, all companies whose drugs are up for Medicare price negotiation will come to the bargaining table. WEKU · Oct 4, 2023
3 Healthcare Stocks to Buy Today The POWR Ratings system points the way to 3 of the most attractive healthcare stocks on the market today. Read on below for why you should consider adding these 3 stocks to your portfolio: Johnson & Johnson (JNJ), Amgen (AMGN) and AbbVie (ABBV). StockNews.com · Sep 18, 2023
Alphabet's Wing CFO Shannon Nash shares her unique path to the C-suite Nash, who is also an award-winning film producer, names Debbie Allen as one of her greatest mentors. Fortune · Sep 8, 2023
Salon · Aug 31, 2023 The history of weight loss drugs "It is no wonder demand for weight-loss drugs continues to soar"
The Conversation · Aug 8, 2023 Ozempic is in the spotlight but it's just the latest in a long and strange history of weight-loss drugs Losing weight conveniently, cheaply, safely. That’s been the holy grail of weight-loss ever since 19th century English undertaker and weight-loss celebrity William Banting’s 1863 Letter on Corpulence spruiked his “miraculous” method of slimming down.
Kiplinger · Aug 7, 2023 Stock Market Today: Dow Outperforms as Amgen, Boeing Gain Ground The main benchmarks closed higher ahead of this week's key inflation update.
The Independent UK · Jun 30, 2023 Cheaper competition for Humira is hitting the market, but savings will depend on your insurance Patients who take the autoimmune disease treatment Humira may see some price relief when several lower-cost, biosimilar versions of the AbbVie drug reach the U.S. market in July
Radio France Internationale · May 26, 2023 Jailed Dutch-Chinese scientist 'forgotten' by his country and company Dr Zhang Mingqiang is in cell number 204 of Shanghai’s notorious Qingpu prison – sentenced to six years for spying. He worked for US pharmaceutical giant Amgen in charge of research and development at their Asian operations. Caught in the crossfire between Beijing, the US and the EU, Zhang and…
Tribune News Service · May 24, 2023 A more aggressive FTC is starting to target drug mergers and industry middlemen Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is moving against drug companies and industry middlemen as part of the Biden administration’s push for lower drug prices at the pharmacy counter.
Barchart · May 16, 2023 Stocks Undercut as Little Progress is seen in U.S. Debt Ceiling Talks What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.01%, and the Nasdaq 100 Index ($IU ) (QQQ ) closed up +0.09%. Stock indexes Tuesday settled mixed, with the Dow Jones...
The Independent UK · May 16, 2023 Monopoly concerns push FTC to sue to block Amgen's more than $26B deal for Horizon Federal regulators are suing to block biotech drug developer Amgen’s more than $26 billion deal for Horizon Therapeutics
Barchart · May 16, 2023 Stocks Mixed as Debt Ceiling Talks Resume What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.16%. U.S. stocks this morning are mixed, with the Dow...
Barchart · May 16, 2023 Markets Today: Stocks Slip Ahead of U.S. Debt Ceiling Talks Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are down -0.26%, and June Nasdaq 100 E-Mini futures (NQM2 3) are down -0.21%. U.S. stock index futures this morning are moderately lower as the markets await any new developments on the debt ceiling stalemate. President Biden will meet...
Tribune News Service · Apr 19, 2023 The drug company that prospered without creating any drugs The new drug looked so promising — except for that one warning sign.